Free tool
FAERS Monitor: Dilaudid-Hp
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019034 or its brand name (Dilaudid-Hp, Hydromorphone Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
91,827
Serious
85,087
93% of reports
Hospitalization
17,193
Death reported
28,204
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug dependence35,119
- overdose23,079
- pain22,354
- emotional distress17,705
- death14,926
- drug withdrawal syndrome14,329
- toxicity to various agents10,084
- nausea4,811
- drug ineffective4,543
- fatigue3,652
- vomiting3,601
- off label use3,489
- anxiety3,395
- drug abuse3,128
- headache3,067
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 287 |
| 2005 | 320 |
| 2006 | 383 |
| 2007 | 437 |
| 2008 | 438 |
| 2009 | 647 |
| 2010 | 866 |
| 2011 | 980 |
| 2012 | 1,400 |
| 2013 | 1,246 |
| 2014 | 1,380 |
| 2015 | 1,964 |
| 2016 | 2,588 |
| 2017 | 3,922 |
| 2018 | 23,055 |
| 2019 | 2,735 |
| 2020 | 8,703 |
| 2021 | 17,398 |
| 2022 | 15,695 |
| 2023 | 2,349 |
| 2024 | 2,204 |
| 2025 | 1,754 |
| 2026 | 1,074 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,962,332 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug dependenceSignal | 35,119 | 63.7 | 63.1 | 1,707,785 |
| drug withdrawal syndromeSignal | 14,329 | 44.5 | 43.8 | 512,008 |
| emotional distressSignal | 17,705 | 39.1 | 38.5 | 563,838 |
| overdoseSignal | 23,079 | 27.3 | 27.0 | 528,030 |
| toxicity to various agentsSignal | 10,084 | 14.5 | 14.2 | 120,153 |
| drug abuseSignal | 3,128 | 8.9 | 8.6 | 21,199 |
| painSignal | 22,354 | 8.6 | 8.5 | 149,286 |
| deathSignal | 14,926 | 4.0 | 4.0 | 34,704 |
| anxietySignal | 3,395 | 2.8 | 2.7 | 3,795 |
| vomiting | 3,601 | 1.8 | 1.7 | 1,199 |
| nausea | 4,811 | 1.4 | 1.4 | 555 |
| headache | 3,067 | 1.1 | 1.1 | 41 |
| fatigue | 3,652 | 1.1 | 1.0 | 20 |
| off label use | 3,489 | 0.9 | 0.9 | 30 |
| drug ineffective | 4,543 | 0.8 | 0.8 | 273 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.